09.00-13.00   FORUM


EUropean REnal and CArdiovascular Medicine Working Group (EURECA-m)

Therapeutic strategies to address the high cardiovascular mortality of CKD patients

Part 1
Chairs: Alberto Ortiz
, Madrid, Spain
             Carmine Zoccali
, Reggio Calabria, Italy

Pulmonary congestion as the key alteration in heart failure and in ESKD

Francesca Mallamaci, Reggio Calabria, Italy

Pros and cons of lipid lowering therapy in CKD: when, how and whom

Andrzej Wiecek, Katowice, Poland

Refocusing on the Mineralo-Receptor: advances in molecular genetics, biology and treatment of cardiovascular and renal diseases

Patrick Rossignol, Vandoeuvre-Les-Nancy, France

Cardiovascular toxicity of protein bound solutes: a methodologic review

Raymond Vanholder, Ghent, Belgium

Part 2
Chairs: Adrian Covic
, Iasi, Romania
             Ziad Massy
, Paris. France 

Bone-vascular axis: application for CKD/ESRD

Gérard London, Fleury-Mérogis, France

Is nutritional phosphate a risk factor in CKD?

Denis Fouque, Lyon, France

Blood pressure monitoring in CKD and recent guidelines

Mehmet Kanbay, Istanbul, Turkey

Acid-base balance and cardiovascular mortality in chronic kidney disease

Miklos Molnar, Toronto, Canada



CME Courses on May 31, 2014 are reserved to regularly registered congress members and are included in the registration fee. In order to participate in the CME Courses, all regularly registered congress members must go to the session halls and have their badge scanned by the hostesses at the entrance (at participant’s own responsibility). Please note that the seat capacity of the conference rooms is limited, therefore participation in these courses will be on a “first come first served” basis.

back to the timetable